IronAid™, a patented, proprietary form of iron, was developed through innovative technology. When compared to conventional forms of iron, IronAid™ demonstrates improved absorption, tolerability, and efficacy. Because IronAid™ is insoluble in the stomach; it does not cause gastric disturbances like conventional forms of iron. IronAid™ has been subjected to numerous clinical studies for safety and efficacy and has been used by over 3,000,000 people with iron deficiency.

THOMAS INCLEDON, MS, RD, LD, LN, NSCA-CPT, CSCS, is a PhD candidate in Exercise Physiology at the University of Miami. He serves as an adjunct faculty member at both Nova Southeastern University and Florida Atlantic University. Tom has degrees in Management, Exercise and Sport Science, Nutrition, and Kinesiology. He has received several awards and fellowships for his academic achievements. He is a licensed nutritionist and dietitian in the state of Florida, and is president of the Incledon Wellness Institute, a nonprofit research center, and serves as a consultant to several nutraceutical companies.

Chemi Nutra is the new US branch of parent company Chemi S.p.A., a privately held pharmaceutical and nutraceutical company based in Milan, Italy. Chemi, with cGMP certified manufacturing facilities in Italy and Brazil, is best known in the US nutritional arena for its introduction of phosphatidyl serine (PS), the popular dietary supplement to enhance memory, and other specialty nutritional ingredients.